The Patent Finder

Remedeye Inc.

Also on record
Records under this name other than patents Remedeye Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Remedeye Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,901,580Methods of Eye Treatment Using Therapeutic Compositions Containing Dipyridamole
Formerly held
Lapsed on the fee record
Ended Feb 27, 2026 · Medium confidence
Lapsed on the fee recordEnded Feb 27, 2026Medium confidence
US 10,973,758Methods of Eye Treatment Using Therapeutic Compositions Containing Dipyridamole
Formerly held
Lapsed on the fee record
Ended Apr 13, 2025 · Medium confidence
Lapsed on the fee recordEnded Apr 13, 2025Medium confidence
US 9,254,289Methods for treating eye disorders using dipyridamole
Formerly held
Lapsed on the fee record
Ended Feb 9, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 9, 2024USPTO record
US 10,357,453Methods of Eye Treatment Using Therapeutic Compositions Containing Dipyridamole
Formerly held
Lapsed on the fee record
Ended Jul 23, 2023 · Medium confidence
Lapsed on the fee recordEnded Jul 23, 2023Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited